Skip to main navigation
Skip to Navigation Skip to Content
Mediclinic InternationalMediclinic International

 

  • Careers
  • Contact
  • Operating Divisions
  • Results Centre
  • News
  • Operating Divisions
  • Results Centre
  • News
Search
Hirslanden Home

Header Links Bottom

  • Operating Divisions
  • Results Centre
  • News

Sidebar Links - Middle

  • About Us
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News

Header Links Top

  • Careers
  • Contact
Hirslanden Home

Sidebar Right Links

About UsAbout Mediclinic InternationalStrategic OverviewPurpose, Vision and ValuesBoard of DirectorsExecutive Management
Our OperationsOperating DivisionsHirslanden - SwitzerlandMediclinic Southern AfricaMediclinic Middle East
Our InvestmentsSpire Healthcare Group - UK
GovernanceGovernance OverviewClinical ServicesCorporate GovernanceRisk ManagementSustainable DevelopmentBusiness Conduct & Ethics
Investor RelationsInvestor Overview
Share PerformanceShare ChartShare CalculatorShare Price Lookup
Results CentreResults and ReportsPresentations and Investor Days
Regulatory News
Investment Case
Investor CalendarUpcoming EventsPast Events
FinancialsFive-Year SummaryValue Added StatementAnalystsDownloads
Shareholder CentreShareholder MeetingsDividendsRegistrarsCirculars & ProspectusesCombination of Mediclinic and AI NoorShareholder Privacy
Investor ContactInvestor RelationsCompany InformationInformation RequestsEmail AlertsCompany Advisors
Media & NewsMedia CentreNews & StoriesSocial MediaMedia Kit
Careers
Financials

Value Added Statement

Five-Year SummaryValue Added StatementAnalystsDownloads

Value Added Statement

The Value added statement depicts the economic benefit created by the Group and how that is distributed among the various stakeholders, comprising employees, shareholders, banks, government, creditors and the economic value retained in the business.

  FY20 FY19
  £’m % £’m %
VALUE CREATED        
Revenue 3 083   2 932  
Cost of materials and services (1 201)   (1 222)  
Finance income 9   9  
Share of net profit of equity accounted investments 2   3  
  1 893 100.0 1 722 100.0
DISTRIBUTION OF VALUE        
To employees as remuneration and other benefits 1 388 73.3 1 233 71.7
Tax and other state and local authority levies (excluding VAT) 71 3.8 68 3.9
To suppliers of capital        
   Non-controlling interests 18 1.0 21 1.2
   Finance cost on borrowed funds 87 4.6 66 3.8
   Distribution to shareholders 59 3.1 59 3.4
  1 623 85.8 1 447 84.0
VALUE RETAINED        
To maintain and replace assets 152 8.0 136 7.9
Income retained for future growth 118 6.2 139 8.1
  270 14.2 275 16.0

Distribution of Value

value added statement

Email Alert Registration

Would you like to receive regular updates about Mediclinic International events and announcements? Then register for email alerts so we can send you all future updates directly.

Email Alerts

Scroll to Top
Mediclinic LogoHirslanden Home
Mediclinic International
  • About Mediclinic International
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News
  • Careers
Contact
© Mediclinic International
Modern Slavery Statement
Terms of Use
Privacy Statement

The website uses cookies to provide necessary site functionality and improve your online experience. By using this website, you agree to the use of cookies as outlined in our recently updated Privacy Notice.